Thomas Kandl is an Ophthalmology physician. OpenAlex indexes 14 publications with 398 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4720 Waters Ave
Savannah, GA 314046292
Telephone
912-629-5968Registry record last updated 10 Jan 2019.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20258 payments
- Tarsus Pharmaceuticals, Inc.Program year20251 payment
- Amgen Inc.Program year202420 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
94%Neuromuscular Blocker94%Onabotulinumtoxina100%Part B, office-administered≥15 patientsSensory organs
5.2%Aminoglycoside Antibacterial4.5%Tobramycin-Dexamethasone70%Neomycin-Polymyxin-Dexameth30%Part D≥71 patientsCorticosteroid0.7%Flarex100%Part D≥14 patientsAnti-infectives
0.8%Macrolide0.8%Erythromycin100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients
British Journal of Ophthalmology
2018 - Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients
Ophthalmic Plastic and Reconstructive Surgery
2018 - Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma
British Journal of Ophthalmology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”